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Abstract: Evidence is emerging that shows elevated mental distress and disorder amongst people
with several neglected tropical diseases (NTDs). This study aimed to establish the prevalence of
depressive symptoms amongst people with podoconiosis and lower limb lymphoedema of other
cause in Cameroon. The study was part of a larger research piece that mapped the geographical
distribution of podoconiosis in Cameroon. The Patient Health Questionnaire (PHQ-9; mean) was
employed to determine the prevalence of depressive symptoms amongst people with lower limb
lymphoedema. Linear regression was used to assess the association between socio-demographic
characteristics of participants and depressive symptoms. Internal consistency of the PHQ-9 was
estimated through Cronbach’s alpha (α = 0.651). The mean PHQ-9 score among people with lower
limb lymphoedema was 3.48 (SD ± 3.25). Using a PHQ-9 score of 5 or above as the cut-off score,
32 participants (38.6%) displayed at least mild depressive symptoms. Unemployment was the only
factor that was significantly associated with more depressive symptoms overall. This study shows
that depressive symptoms are common amongst people with lower limb lymphoedema in Cameroon.
The findings provide support for the integration of psychosocial interventions into packages of care
for the management of lower limb lymphoedema.
Keywords: neglected tropical diseases; lymphoedema; podoconiosis; mental health; depression;
prevalence
1. Introduction
Lower limb lymphoedema refers to swelling of the lower leg and feet, and may be caused by
several neglected tropical diseases (NTDs), including podoconiosis, lymphatic filariasis (LF), and
leprosy. Whilst the latter two conditions are caused by parasites and Bacillus, respectively, podoconiosis
is associated with long-term exposure to irritant red clay tropical soils [1] that occur where ancient
volcanic deposits have weathered [2] at high altitude and where there is heavy rainfall.
Approximately 20 million people worldwide are thought to be affected by lymphoedema due to
the three diseases—15 million due to LF [3], an estimated 4 million due to podoconiosis [4], and 200,000
registered with leprosy [5]. Recent nationwide mapping in Cameroon found the overall prevalence of
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lower limb lymphoedema to be 0.8% (with rates varying across regions), of which the majority (62.7%)
were podoconiosis cases [6]. This amounts to an estimated 41,556 podoconiosis cases in Cameroon [7].
Other countries with a high burden of podoconiosis include Ethiopia, Uganda, Kenya, and Tanzania [8].
Lower limb lymphoedema imposes huge burdens on affected individuals, their families and
communities, not only in terms of physical disability [9], but also in terms of mental distress [10],
depression [11], stigma [9,12–15], and loss of economic productivity [16–18]. Previous studies have
found levels of depression to be 20% amongst people with LF in Nigeria using the Patient Health
Questionnaire (PHQ-9) as a screening tool and the Depression module of the Composite International
Diagnostic Interview (CIDI) as a diagnostic tool [19], and depressive symptoms to be 12.6% amongst
people with podoconiosis in Northern Ethiopia as measured by the PHQ-9 [11]. This, together with
the stigma that often accompanies lower limb lymphoedema, significantly increases the burden of
disease [20], and also acts as a major barrier to accessing and adhering to morbidity management and
disability prevention (MMDP) services for lower limb lymphoedema [21,22]. For LF, there is evidence
that the burden of the associated psychological and emotional consequences of the condition is double
that of the burden of the physical disease measures [20].
This paper reports on the prevalence of depressive symptoms amongst people with podoconiosis
and lower limb lymphoedema of other cause in Cameroon.
2. Materials and Methods
2.1. Design
This research was part of a larger study by Deribe et al. (2018) [6] that aimed to determine the
prevalence and geographical distribution of podoconiosis in Cameroon, to estimate the population
at risk, and to establish which areas qualify for control programs. For this, a population-based
cross-sectional survey was conducted to identify people with podoconiosis or lower limb lymphoedema
of other cause, using a multi-stage cluster sampling design with stratification of the country by
environmental risk of podoconiosis (which includes precipitation, altitude, clay and silt fraction of soil,
population density, enhanced vegetation index, distance from water body, and slope of land) [6].
The results reported in this paper are those of a sub-study within the larger mapping study,
looking at the prevalence of depressive symptoms amongst those people identified as having lower
limb lymphoedema (either podoconiosis or lymphoedema of other cause) in the larger study.
2.2. Setting
The study was conducted within households of participants in 76 villages from 40 health districts
across all ten administrative regions in Cameroon.
2.3. Sample
A minimum sample size of 3933 from 80 clusters was established for the larger mapping study
based on 95% confidence intervals, an assumed design effect of 15, and the ability to detect a prevalence
rate of 0.5% with 0.9% precision and 10% non-response rate. Multi-stage sampling of clusters was
used, with 40 health districts selected randomly from the total number of 189 districts for the first
stage (divided proportionally according to risk of podoconiosis), and then with two villages selected
randomly within each of the chosen health districts during the second stage. Within the 76 villages
accessed, all participants who were at least 15 years old and had lived in the health district for at least
ten years were surveyed, as long as they were sufficiently healthy to be interviewed [6].
Based on this sampling procedure, 10,178 individuals from 4603 households were included in the
larger mapping study; of those, 83 (0.8%) people were identified as having lower limb lymphoedema
and were included in the study reported here.
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2.4. Procedure
In the larger mapping study, all 10,178 eligible participants were surveyed and screened for
lymphoedema via a physical examination to detect signs of limb lymphoedema and hydrocele (men
only for the latter). Podoconiosis versus lymphoedema of other cause was diagnosed using a clinical
algorithm, as follows: all 83 participants who were identified as having lower limb lymphoedema
were administered a questionnaire in which they were asked about demographic and socio-economic
information, their shoe-wearing and foot care practices, other morbidities, and their leg swelling
history test results. Clinical history, physical examination, and disease-specific tests were then used to
reach the diagnosis of podoconiosis, and to exclude the common differential diagnoses such as LF,
systemic disease, and leprosy [6].
In addition, the questionnaire that was administered to the 83 participants who were identified as
having lower limb lymphoedema contained the 9-item PHQ-9 as a measure of depressive symptoms.
The PHQ-9 has been used and validated as a measure of depression in a wide range of settings [23,24],
including in Cameroon [25,26]. The scale involves asking the person how often they have been affected
by a set of nine problems over the last two weeks, for example, having little interest or pleasure in doing
things, feeling tired or having little energy, having poor appetite or overeating, and having trouble
concentrating. The PHQ-9 scores were classified in this study according to categories that have been
widely used [11], including in Cameroon [26], as follows: no depression (0–4), mild (5–9), moderate
(10–14), moderately severe (15–19), and severe depression (20–27). Interviews were conducted in either
French or English; in cases where the participant spoke neither, translators were used to translate the
French or English into their local language. Translators held a degree as a minimum qualification, and
were briefed on the study rationale and objectives.
All data were collected using BLU smartphones and uploaded to the Cloud-based LINKS server
using software developed and supported by the NTD Support Centre [27].
Ethics approval for this study was obtained as part of the larger mapping study from the Cameroon
National Ethics Committee (CNEC) and the Brighton and Sussex Medical School Research Governance
and Ethics Committee (RGEC). Participants gave their written informed consent to take part in
the study.
2.5. Analysis
Data analyses were conducted using IBM SPSS 24. Descriptive analyses (frequencies and
percentages for categorical variables, and means with standard deviations for continuous variables) were
used to present the socio-demographic and disease characteristics of participants, both for people with
podoconiosis and those with lower limb lymphoedema of other cause. Chi-square (categorical variables;
using Yates’ correction where expected cell counts were below 10) and independent t-tests (continuous
variables) were employed to assess whether there were any differences in socio-demographic and
disease characteristics between participants who had podoconiosis versus those who had lymphoedema
of other cause.
To determine prevalence of depressive symptoms amongst people with podoconiosis and lower
limb lymphoedema of other cause, the mean total PHQ-9 score was calculated. An independent
t-test was used to assess whether there were any differences in PHQ-9 scores between participants
with podoconiosis and lower limb lymphoedema of other cause. Cronbach’s alpha was computed as
a measure of internal consistency for the PHQ-9 in order to assess whether the PHQ-9 was able to
reliably measure depression within this population; a higher Cronbach’s alpha score indicates a higher
likelihood that all items in the scale measure the same underlying construct.
A standard multivariate linear regression model was employed to assess the association between
the socio-demographic characteristics of participants and depressive symptoms, with PHQ-9 score
(depressive symptoms) as the dependent variable, and the following factors as independent variables:
age, sex, level of education, and employment status; the independent variables were selected into the
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model based on the results of previous studies and prior correlational analyses. Dummy variables
were created in SPSS for the categorical variables before they were entered into the regression model.
A significance level of 0.05 was employed for all analyses.
3. Results
Table 1 shows the socio-demographic and disease characteristics of those 83 people identified in
the larger mapping study as having either podoconiosis (n = 52; 62.7%) or lower limb lymphoedema of
other cause (n = 31; 37.3%) (out of the total 10,178 people sampled). Participants who were classed as
having lower limb lymphoedema of other cause included 15 people who had swelling characteristic of
LF (i.e., swelling of the descending type) [28], four who had signs and symptoms of other diseases,
four where the swelling had started below 3 years of age, three known-leprosy patients, three with
hydrocele, one person with loss of sensation, and one where the lymphoedema had developed after a
major surgical procedure.
Table 1. Socio-demographic and disease characteristics of people with lower limb lymphoedema
in Cameroon.
Characteristics Total(n = 83)
Podoconiosis
(n = 52)
Lymphoedema of Other Cause
(n = 31)
Sex
Male 42 (50.6%) 28 (53.8%) 14 (45.2%)
Female 41 (49.4%) 24 (46.2%) 17 (54.8%)
Age, mean in years 52.6 (SD = 19.6) 49.83 (SD = 17.42) 57.32 (SD = 22.36)
Marital status
Married 43 (51.8%) 30 (57.7%) 13 (41.9%)
Widowed 18 (21.7%) 8 (15.4%) 10 (32.3%)
Single 18 (21.7%) 11 (21.2%) 7 (22.6%)
Divorced 4 (4.8%) 3 (5.8%) 1 (3.2%)
Religion
Christian 67 (80.7%) 42 (80.8%) 25 (80.6%)
Muslim 10 (12.0%) 7 (13.5%) 3 (9.7%)
Animist 1 (1.2%) 0 1 (3.2%)
Other 5 (6.0%) 3 (5.8%) 2 (6.5%)
Level of education
No formal education 38 (45.8%) 25 (48.1%) 13 (41.9%)
Primary school 27 (32.5%) 15 (28.8%) 12 (38.7%)
Secondary school 17 (20.5%) 11 (21.2%) 6 (19.4%)
Tertiary education 1 (1.2%) 1 (1.9%) 0
Literate
Yes 40 (48.2%) 27 (51.9%) 13 (41.9%)
No 43 (51.8%) 25 (48.1%) 18 (58.1%)
Employment status
Employed 60 (72.3%) 40 (76.9%) 20 (64.5%)
Not employed 18 (21.7%) 10 (19.2%) 8 (25.8%)
Student 5 (6.0%) 2 (3.8%) 3 (9.7%)
Retired 0 0 0
Occupation
Farmer 44 (53.0%) 26 (50.0%) 18 (58.1%)
Businessman/woman 8 (9.6%) 8 (15.4%) 0
Housewife 5 (6.0%) 3 (5.8%) 2 (6.5%)
Labourer 3 (3.6%) 2 (3.8%) 1 (3.2%)
Student 5 (6.0%) 21 (3.8%) 3 (9.7%)
Jobless 11 (13.3%) 7 (13.5%) 4 (12.9%)
Other 7 (8.4%) 4 (7.7%) 3 (9.7%)
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Table 1. Cont.
Characteristics Total(n = 83)
Podoconiosis
(n = 52)
Lymphoedema of Other Cause
(n = 31)
Mean number of years in
current location 42.2 (SD = 21.0) 39.44 (SD = 19.82) 46.71 (SD = 22.34)
Family member with history of
leg swelling
Yes 18 (21.7%) 11 (21.2%) 7 (22.6%)
No 65 (78.3%) 41 (78.8%) 24 (77.4%)
Disease stage (1–5) *, mean 2.60 (SD = 1.14) 2.65 (SD = 1.11) 2.50 (SD = 1.24)
Years since onset of swelling,
mean 17.84 (SD = 13.91) 17.58 (SD = 12.53) 18.29 (SD = 16.18)
Co-morbidity present
Upper limb lymphoedema 9 (10.8%) 4 (7.7%) 5 (16.1%)
Breast lymphoedema 1 (1.2%) 0 1 (3.2%)
Vulva or penis lymphoedema 2 (2.4%) 0 2 (6.5%)
Hydrocele 3 (3.6%) 0 3 (9.7%)
Chyluria (milky urine) 5 (6.0%) 3 (5.8%) 2 (6.5%)
* The staging system by Tekola et al. (2008) [29] was used, where 1 denotes the least severe disease stage and 5 marks
the most severe disease stage.
There were no statistically significant differences for any of the socio-demographic or disease
characteristics between those who had podoconiosis compared to those who had lymphoedema of
other cause.
In regard to prevalence of depressive symptoms, the mean PHQ-9 score amongst participants was
3.48 (SD = 3.25), ranging between 0 and 15 (out of a possible score of 27). Cronbach’s alpha for the
PHQ-9 was 0.651, which is on the low end of a satisfactory score.
Using a PHQ-9 score of 5 or above as the cut-off score, 32 people (38.6%) with lower limb
lymphoedema were classified as having at least mild depressive symptoms (see Table 2). Amongst
people who scored above the cut-off score of 5, the mean PHQ-9 score was 6.88 (SD = 2.31).
Table 2. Depressive symptoms reported by participants.
Level of Depressive Symptoms





Lymphoedema of Other Cause
(n = 31)
No depression (0–4) 51 (61.4%) 33 (63.5%) 18 (58.1%)
Mild (5–9) 29 (34.9%) 16 (30.8%) 13 (41.9%)
Moderate (10–14) 2 (2.4%) 2 (3.8%) 0
Moderately severe (15–19) 1 (1.2%) 1 (1.9%) 0
Severe (20–27) 0 0 0
There were no significant differences in levels of depressive symptoms between people with
podoconiosis (mean = 3.38, SD = 3.5) and those with lower limb lymphoedema of other cause
(mean = 3.65, SD = 2.82) (p = 0.73), though the only people who reported either moderate or moderately
severe depressive symptoms had podoconiosis (see Table 2).
In the multivariate standard linear regression model, only unemployment proved to be a significant
predictor (B = 1.87, 95% CIs: 0.13–3.62, p = 0.36, R2 = 0.12), with those people who were unemployed
having higher PHQ-9 scores on average than those who were not classed as unemployed, i.e., those
who were either employed, retired, or students (mean PHQ-9 score unemployed: 4.89, SD = 2.59,
compared to a mean of 3.09, SD = 3.32 for people who were not unemployed); none of the other
variables were significant predictors.
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4. Discussion
Depressive symptoms were found to be common amongst people with podoconiosis and lower
limb lymphoedema of other cause in Cameroon, with over one-third of participants (38.5%) displaying
at least some degree of depressive symptoms, though the large majority of these were classified as
having mild depression levels.
These results are very similar to those from a study in Ethiopia by Bartlett et al. (2016) [11] that
employed a more rigorous method of establishing depression amongst people with podoconiosis, by
measuring depression at two time points. In this Ethiopian study, 37.3% of participants displayed
PHQ-9 scores of 5 or above at the time of the first measurement. Of those, around a third, i.e., 12.6% of
the total number of participants (compared to 0.7% of their healthy neighbours), still displayed PHQ-9
scores of 5 or above two weeks later. It is this more conservative figure of 12.6% that the authors used
to estimate prevalence of depression [11]. Given that the initial rate of 37.3% is very similar to the
findings in the study reported here, it is possible—though untested—that this could also be the case in
Cameroon. Depression is usually established based on symptoms being present for at least two weeks,
so a repeat assessment of the PHQ-9 two weeks after the first assessment may possibly result in a more
accurate prevalence estimate.
The study in Nigeria that used the PHQ-9 as a screening tool and the CIDI as a diagnostic tool
for depression in people with LF [19] did not report the number of participants in their study who
screened positive for depression using the PHQ-9, so comparisons cannot be made with that study.
There was little variation in depressive symptoms according to socio-demographic or disease
characteristics, with unemployment being the only factor that was significantly associated with
higher depressive symptoms overall. This is in line with the LF study from Nigeria, which found
unemployment to be predictive of depression [19]. However, due to the cross-sectional nature
of these studies, they are not able to verify the causal relationship between unemployment and
depressive symptoms for people with lymphoedema. Research from the wider mental health field
has demonstrated the possible bi-directionality or negative cycle of these variables, i.e., that factors
associated with poverty such as unemployment can cause mental ill-health and that the reverse is also
the case, and it would be interesting for future research to explore this association further within this
particular population [30].
There were several limitations to this study, of which one is that the results may have been biased
because the PHQ-9 has—to our knowledge—not been validated amongst this study population in
Cameroon (even though it has been validated there amongst people living with HIV [26] and with
medical students [25], and has been used in the country within research on numerous occasions);
its reliability has also not been established in Cameroon. Since internal consistency for the PHQ-9
was reasonable rather than high in this study, further reliability and validity testing of the PHQ-9 in
Cameroon would have strengthened the results of this study. A previous study that validated the
PHQ-9 in Cameroon for people living with HIV found that the tool had low sensitivity (though high
specificity) for picking up major depressive disorder (MDD), defined as a cut-off score of 10 or more;
however, their finding of 3% prevalence for MDD is comparable to the results in the study reported
here, where 3.6% of participants had a PHQ-9 score of 10 or more [26]. Other studies, such as the one
by Bartlett et al. (2016) [11] mentioned above, have also used more rigorous methods in establishing
depression. A further limitation is that no control group was included in the study as a comparator for
depressive symptoms (since this was beyond the scope of the larger mapping study), such as people
without lymphoedema living in the same circumstances. The relatively small sample size is another
limitation, which may have decreased the study’s power in finding significant effects, for example,
when comparing the sociodemographic and disease characteristics of participants with podoconiosis
to those who had lower limb lymphoedema of other cause, or during the regression analysis.
Despite the limitations, this study contributes to a growing body of evidence which shows that
mental distress and disorder is common amongst people with lower limb lymphoedema such as
podoconiosis [10,11,19], thereby greatly increasing the burden associated with the conditions [20].
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This research thus highlights further the importance of taking a holistic approach, and integrating
psychosocial interventions into MMDP care packages for people with lower limb lymphoedema, to
treat not only affected people’s physical symptoms and disabilities but to also improve their mental
wellbeing. Only then can the burden associated with these conditions be truly addressed.
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